Oxbow Advisors LLC bought a new stake in Ventas, Inc. (NYSE:VTR – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 19,733 shares of the real estate investment trust’s stock, valued at approximately $1,752,000.
A number of other large investors have also recently bought and sold shares of the stock. Deutsche Bank AG grew its holdings in shares of Ventas by 0.7% during the fourth quarter. Deutsche Bank AG now owns 3,904,293 shares of the real estate investment trust’s stock worth $302,114,000 after buying an additional 27,688 shares in the last quarter. Bank of New York Mellon Corp raised its position in shares of Ventas by 2.5% in the fourth quarter. Bank of New York Mellon Corp now owns 2,868,962 shares of the real estate investment trust’s stock valued at $222,000,000 after buying an additional 70,459 shares during the last quarter. Norges Bank purchased a new position in shares of Ventas during the fourth quarter valued at approximately $474,571,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in shares of Ventas by 7.4% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,346,111 shares of the real estate investment trust’s stock valued at $104,095,000 after buying an additional 92,236 shares during the period. Finally, Cbre Investment Management Listed Real Assets LLC boosted its position in Ventas by 5.8% during the fourth quarter. Cbre Investment Management Listed Real Assets LLC now owns 1,851,968 shares of the real estate investment trust’s stock worth $143,305,000 after acquiring an additional 101,370 shares during the last quarter. Institutional investors and hedge funds own 94.18% of the company’s stock.
Insider Transactions at Ventas
In other Ventas news, Director Michael J. Embler purchased 2,500 shares of the business’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were purchased at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the acquisition, the director owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. This represents a 14.97% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.53% of the company’s stock.
Analyst Ratings Changes
View Our Latest Stock Report on Ventas
Ventas Price Performance
VTR stock opened at $91.24 on Wednesday. The company has a market cap of $46.80 billion, a PE ratio of 168.96, a price-to-earnings-growth ratio of 2.11 and a beta of 0.69. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.86. The stock has a 50-day moving average price of $90.86 and a two-hundred day moving average price of $86.83. Ventas, Inc. has a 12-month low of $66.38 and a 12-month high of $101.60.
Ventas (NYSE:VTR – Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The real estate investment trust reported $0.97 EPS for the quarter, topping analysts’ consensus estimates of $0.96 by $0.01. The company had revenue of $1.73 billion for the quarter, compared to the consensus estimate of $1.68 billion. Ventas had a return on equity of 1.99% and a net margin of 4.08%.The company’s quarterly revenue was up 21.7% compared to the same quarter last year. During the same period last year, the business posted $0.87 EPS. As a group, research analysts predict that Ventas, Inc. will post 3.89 EPS for the current year.
About Ventas
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
See Also
- Five stocks we like better than Ventas
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
